ActiGraft is an Autologous blood derived product for chronic, non-healing wounds (including diabetic wounds) which constructs a whole blood clot (WBC) gel that contains whole cells: white cells, red cells, plasma, platelets, fibrin, stem cells, and fibrocyte precursors. The gel is used by physicians in clinical settings in treating chronic, non-healing wounds, open cutaneous wounds, and soft tissue. The procedure includes administration, dressings, phlebotomy, mixing, and other preparatory procedures, per treatment.